Hermes Garcia, MD
Neurological Surgery · Orlando, FLNPI 1447480611
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 23.0%. Reporting peaked in 2020 at $1,244 and has fallen 62.1% since, to $471 in 2025. That places this record below the midpoint for neurological surgery clinicians in FL, where the typical reported total is $5,245.
Across 64 payments — averaging $53.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$792
- Mizuho America, Inc.$710
- Zimmer Biomet$380
- Gilead$250
- Integra Lifesciences Corporation$240
- GT Medical Technologies, Inc$178
- plus $897 from 18 others
Across 3 payments — averaging $5666.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GT Medical Technologies, Inc$17K
What the payments were for
- Speaking & faculty fees$130%
- Travel & lodging$1,12233%
- Food & beverage$1,92156%
- Education$35010%
- Entertainment$421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 7 | $792 |
| Mizuho America, Inc. | 3 | $710 |
| Zimmer Biomet | 6 | $380 |
| Gilead | 3 | $250 |
| Integra Lifesciences Corporation | 13 | $240 |
| GT Medical Technologies, Inc | 3 | $178 |
| Johnson & Johnson | 4 | $144 |
| Si-bone, Inc. | 4 | $138 |
| Omniscient Neurotechnology America Ltd | 1 | $124 |
| Smith+Nephew | 3 | $92 |
| AbbVie | 2 | $65 |
| Brainlab, Inc. | 1 | $44 |
| Flowonix Medical Incorporated | 1 | $42 |
| Aesculap, Inc. | 1 | $39 |
| Stryker | 2 | $38 |
| Travere Therapeutics, Inc. | 2 | $29 |
| Monteris Medical Corporation | 1 | $29 |
| Viiv Healthcare Company | 1 | $22 |
| Ossdsign USA Incorporated | 1 | $18 |
| Abbott | 1 | $16 |
| Nevro Corp. | 1 | $15 |
| Inspiremd Ltd | 1 | $15 |
| BK Medical Holding Company Inc. | 1 | $14 |
| Irras USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,448 in reported general payments places this provider in the 40th percentile of 556 neurological surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurological surgery in Orlando
- Kim ManwaringOrlando$5M
- Avery BuchholzOrlando$790K
- Hunaldo VillalobosOrlando$517K
- Virgilio MatheusOrlando$485K
- Jogi PattisapuOrlando$238K
- Joseph WehmanOrlando$167K
- Jay VachhaniOrlando$149K
- Stephen ParkerJacksonville$18.7M
- Eric PetersonMiami$10.1M
- Brian SnellingBoca Raton$10M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.